Maalox RefluRAPID oral suspension 20 single-dose sachets of 10 ml

Origin

Maalox RefluRAPID oral suspension 20 single-dose sachets of 10 ml, sold under the maalox brand, is manufactured in United States of America. That origin is recorded at the "Internet-Sourced" evidence grade.

maalox is headquartered in France; a brand's home country is not evidence of where its goods are made, and the two are tracked separately.

Origin evidence last reviewed 2026-06-29.

Every origin claim on Hesperia Market is graded by the strength of its evidence and linked to its sources.